Premium
COMPREHENSIVE REPORT OF ANTI‐CD19 CHIMERIC ANTIGEN RECEPTOR T‐CELLS (CAR‐T) ASSOCIATED NON RELAPSE MORTALITY (CART‐NRM) FROM FAERS
Author(s) -
Anand K.,
Pingali S.,
Ensor J.,
Neelapu S.S.,
Iyer S.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.121_2630
Subject(s) - medicine , chimeric antigen receptor , cart , lymphoma , adverse effect , aggressive lymphoma , blinatumomab , oncology , population , immunology , cd19 , immunotherapy , rituximab , cancer , peripheral blood , environmental health , mechanical engineering , engineering